Literature DB >> 9130636

Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation.

I Vouldoukis1, P A Bécherel, V Riveros-Moreno, M Arock, O da Silva, P Debré, D Mazier, M D Mossalayi.   

Abstract

The host response to Leishmania infection is regulated by a specific pattern of local cytokine production. We investigated the effect of interleukin (IL)-10 and IL-4 on the leishmanicidal activity of human macrophages (M phi). As with L. major, intracellular killing of L. infantum by human M phi was obtained following ligation of surface CD23 or cell treatment with interferon-gamma (IFN-gamma). This leishmanicidal activity required nitric oxide (NO) generation by activated M phi, and it was partially mimicked by cell treatment with chemical NO donors. Addition of recombinant human IL-10 or IL-4 to CD23 mAb or IFN-gamma decreased L. infantum and L. major killing by infected M phi. IL-10 was more potent than IL-4 in inhibiting the leishmanicidal activity of human M phi. Inhibition of Leishmania killing by IL-4 and IL-10 correlated with decreased NO generation from M phi, and was reversed when exogenous NO was added to cell cultures. Therefore, IL-10 and IL-4 down-regulate leishmanicidal activity of human M phi, in part by inhibiting NO generation by these cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130636     DOI: 10.1002/eji.1830270409

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  49 in total

1.  A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.

Authors:  I Suffia; B Ferrua; X Stien; B Mograbi; P Marty; D Rousseau; K Fragaki; J Kubar
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection.

Authors:  Fabiola Cardillo; Edilberto Postol; Jorge Nihei; Luiz S Aroeira; Auro Nomizo; José Mengel
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

3.  Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors:  Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

4.  Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation.

Authors:  Nam-Kha Pham; Jennifer Mouriz; Peter E Kima
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB/c mice.

Authors:  Bahareh Vakili; Navid Nezafat; Bijan Zare; Nasrollah Erfani; Maryam Akbari; Younes Ghasemi; Mohammad Reza Rahbar; Gholam Reza Hatam
Journal:  Med Microbiol Immunol       Date:  2019-11-06       Impact factor: 3.402

6.  T cells that react to the immunodominant Leishmania major LACK antigen prevent early dissemination of the parasite in susceptible BALB/c mice.

Authors:  S Schilling; N Glaichenhaus
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania.

Authors:  Marion Man-Ying Chan; Naga Suresh Adapala; Dunne Fong
Journal:  Parasitol Res       Date:  2005-03-17       Impact factor: 2.289

8.  Age modifies the immunologic response and clinical presentation of American tegumentary leishmaniasis.

Authors:  Augusto M Carvalho; Camila F Amorim; Juliana L S Barbosa; Alexsandro S Lago; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

Review 9.  Leishmania interferes with host cell signaling to devise a survival strategy.

Authors:  Suvercha Bhardwaj; Neetu Srivastava; Raki Sudan; Bhaskar Saha
Journal:  J Biomed Biotechnol       Date:  2010-04-08

Review 10.  Interactions between worm infections and malaria.

Authors:  Mathieu Nacher
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.